CVPR Week 8: Renal handling of P Flashcards
Phosphorus flux between body compartments

Why is keeping phosphate levels in the normal range important
It is required to permit normal calcium deposition and retrieval from bone
Mechanisms of intestinal phosphorus absorption
- Between cells (paracellular)
- through cells (intracellular)

Features of paracellular intestinal phosphorus absorption
- Passive process
- Quantitatively significant when intake is high
Features of transcellular intestinal phosphorus absorption
- Active process
- Influenced by calcitriol
- Calbindin: acts as an intracellular sink to reduce the microvilli [Ca]
Describe renal handling of phosphorus
- PCT 85%
- TAHL 10%
- DCT 3%
- CD 2%

Main mechanism of proximal tubule phosphorus transport
entirely transcellular driven by sodium transport
What gets absorbed in the proximal tubule?
Most stuff (glucose, phosphorus, calcium, amino acids, ketoacids) get absorbed with sodium in the proximal tubule
What is the mechanism of volume depletion and depleted potassium stores in diabetic ketoacidosis?
(ketoaciduria -> increased ketone body reabsorption in the PT -> reduced availability of Na+ for the reabsorption of proximal tubule substrates)
Proximal tubule phosphorus handling

Factors that increase renal absorption of phosphorus
3 listed
- Low-phosphate diet
- 1, 25-Vitamin D3
- Thyroid hormone
Factors that decrease renal absorption of phosphorus
9 listed
- Parathyroid hormone
- Phosphatonins (e.g FGF23)
- High-phosphate diet
- Metabolic acidosis
- Potassium deficiency
- Glucocorticoids
- Dopamine
- Hypertension
- Estrogen
Describe Paraneoplastic tumor-induced osteomalacia
Release of FGF23 by cancer cells: bone pain/fractures/weakness from hypophosphorus
What is FGF23?
Fibroblast growth factor 23 is a phosphantonin and is a key regulator of phosphorus homeostasis
FGF23 AKA
Fibroblast Growth Factor 23
What is a phosphatonin?
i.e. hormone regulating Phosphorus excretion
Where is FGF23 produced?
exclusively in osteocytes and bone-lining cells
FGF23 synthesis is influenced by?
Synthesis increases by
- Phosphorus
- PTH
- Calcitriol
The most rapid inducer of FGF23 expression is?
Calcitriol
How can diet effect FGF23?
A high phosphorus dietary intake can stimulate FGF23 expression
Where is the FGF23 receptor
FGF23R is in the kidney
Describe the FGF23-R
found in the kidney and requires the coreceptor Klotho (which is found in the parathyroids) which decrease in number in aging and CKD
FGF23-R coreceptor
Klotho
CKD AKA
Chronic Kidney Disease
Actions of FGF23
4 listed
- Downregulates luminal sodium/phosphate cotransporters in the proximal tubule
- Inhibits 1α-hydroxylase which decreases calcitriol
- Stimulates 24-hydroxylase which degrades vitamin D
- Inhibits PTH secretion
Resulting in:
Lowering of serum phosphorus
FGF23 overall effect
Lowering of serum phosphorus
Inhibiting 1α-hydroxylase has what effect?
decreases calcitriol
Stimulating 24-hydroxylase has what effect?
Degrades Vitamin D
Describe the integrated regulation of renal P excretion

Mechanisms of hypophosphatemia
Shift into cells
Decreased intestinal absorption
Decreased intake (starvation/alcoholism)
Increased renal loss of phosphate (phosphate wasting)
Mechanisms of hyperphosphatemia
5 listed
- Drop in renal function (acute or CKD)
or more common causes
- Increased intake (oral sodium laxatives)
- Increased tubular reabsorption of phosphate
- increased tissue release
- Shift out of cells
Fanconi syndrome and phosphorus
NaP transporter mutation causes phosphate wasting
NaP transporter mutation that results in phosphate wasting?
Fanconi Syndrome
Alcoholism and phosphate
- will have low phosphorus level
- If they are not alcoholic then they might have Fanconi Syndrome
When phosphorus is high what should you look for?
Look for tissue release (rhabdomyolysis) or poor kidney function
Hypophosphatemia clinical manifestations
- Manifestations depend on the acuity and chronicity
- Symptoms due to changes in mineral metabolism
- Symptoms due to ATP depletion
What are the symptoms due to ATP depletion?
5 listed
- Metabolic encephalopathy, impaired myocardial function
- Respiratory failure
- myopathy
- Dysphagia, ileus
- Hemolytic anemia
Hyperphosphatemia clinical manifestations
- Acute elevation of phosphorus may lead to acute kidney injury and failure (phosphate nephropathy)
- Chronic elevations (CKD) lead to cardiovascular calcification and increased cardiovascular morbidity and mortality
Tx of Acute severe hypophosphatemia of < 1 mg/dL
IV phosphate replacement
Tx of chronic hypophosphatemia
oral phosphorus with vitamin D
Adverse effects of phosphate therapy
- phosphate therapy can aggravate hypocalcemia
- in hypercalcemic patients, acute loading may lead to calcium phosphate precipitation and nephrocalcinosis
Tx of hyperphosphatemia
- Phosphate binders (CKD)
- Dialysis
- Tumor lysis
- Rhabdomyolysis
Lab profile calcium and phosphate disorders

Hypoparathyroidism PTH
decreased
Hypoparathyroidism calcitriol
decreased
Hypoparathyroidism calcium
decreased
Hypoparathyroidism phosphorus
decreased
Hypoparathyroidism eGFR
normal
Pseudohypoparathyroidism: Type 1A GNAS mutations/Albright syndrome
PTH
Increased
Pseudohypoparathyroidism: Type 1A GNAS mutations/Albright syndrome
Calcitriol
decreased
Pseudohypoparathyroidism: Type 1A GNAS mutations/Albright syndrome
Calcium
Decreased
Pseudohypoparathyroidism: Type 1A GNAS mutations/Albright syndrome
Phosphorus
Increased
Pseudohypoparathyroidism: Type 1A GNAS mutations/Albright syndrome
eGFR
normal
Pseudohypoparathyroidism: Type 1B GNAS mutations/Usually without skeletal defects of Albright syndrome
PTH
Increased
Pseudohypoparathyroidism: Type 1B GNAS mutations/Usually without skeletal defects of Albright syndrome
Calcitriol
Decreased
Pseudohypoparathyroidism: Type 1B GNAS mutations/Usually without skeletal defects of Albright syndrome
Calcium
Decreased
Pseudohypoparathyroidism: Type 1B GNAS mutations/Usually without skeletal defects of Albright syndrome
Phosphorus
Increased
Pseudohypoparathyroidism: Type 1B GNAS mutations/Usually without skeletal defects of Albright syndrome
eGFR
Normal
Pseudohypoparathyroidism: Type 2
PTH
increased
Pseudohypoparathyroidism: Type 2
Calcitriol
decreased
Pseudohypoparathyroidism: Type 2
Calcium
Decreased
Pseudohypoparathyroidism: Type 2
Phosphorus
Increased
Pseudohypoparathyroidism: Type 2
eGFR
Pseudopseudohypoparathyroidism
PTH
Normal
Pseudopseudohypoparathyroidism
Calcitriol
Normal
Pseudopseudohypoparathyroidism
Calcium
Normal
Pseudopseudohypoparathyroidism
Phosphorus
Normal
Pseudopseudohypoparathyroidism
eGFR
Normal
Vitamin D Deficiency
PTH
Increased
Vitamin D Deficiency
Calcitriol
Decreased
Vitamin D Deficiency
Calcium
Decreased
Vitamin D Deficiency
Phosphate
decreased
Vitamin D Deficiency
eGFR
Primary Hyperparathyroidism
PTH
Increased
Primary Hyperparathyroidism
Calcitriol
increased
Primary Hyperparathyroidism
Calcium
increased
Primary Hyperparathyroidism
Phosphate
decreased
Primary Hyperparathyroidism
eGFR
Normal or decreased
Secondary Hyperparathyroidism
PTH
Increased
Secondary Hyperparathyroidism
Calcitriol
normal or low
Secondary Hyperparathyroidism
calcium
normal or low
Secondary Hyperparathyroidism
phosphate
high
Secondary Hyperparathyroidism
eGFR
low
Tertiary Hyperparathyroidism
PTH
high
Tertiary Hyperparathyroidism
Calcitriol
normal or low
Tertiary Hyperparathyroidism
Calcium
high
Tertiary Hyperparathyroidism
phosphate
high or normal
Tertiary Hyperparathyroidism
eGFR
low